» Articles » PMID: 15777850

TGF-beta1-mediated Activations of C-Src and Rac1 Modulate Levels of Cyclins and P27(Kip1) CDK Inhibitor in Hepatoma Cells Replated on Fibronectin

Overview
Specialties Biochemistry
Biophysics
Date 2005 Mar 22
PMID 15777850
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Integrin-mediated cell adhesion transduces signals to regulate actin cytoskeleton and cell proliferation. While understanding how integrin signals cross-talk with the TGF-beta1 pathways, we observed lamellipodia formation and cyclin regulation in Hep3B cells, following TGF-beta1 treatment. To answer if integrin signaling via actin organization might regulate cell cycle progression after TGF-beta1 treatment, we analyzed cross-talk between the two receptor-mediated pathways in hepatoma cells on specific ECMs. We found that basal and TGF-beta1-mediated activation of c-Src and Rac1, expression of cyclins E and A, and suppression of p27Kip1 were significant in cells replated on fibronectin, but not in cells on collagen I, indicating a different integrin-mediated cellular response to TGF-beta1 treatment. Levels of tyrosine phosphorylation and actin-enriched lamellipodia on fibronectin were also more prominent than in cells on collagen I. Studies using pharmacological inhibitors or transient transfections revealed that the preferential TGF-beta1 effects in cells on fibronectin required c-Src family kinase activity. These observations suggest that a specific cross-talk between TGF-beta1 and fibronectin-binding integrin signal pathways leads to the activation of c-Src/Rac1/actin-organization, leading to changes in cell cycle regulator levels in hepatoma cells. Therefore, this study represents another mechanism to regulate cell cycle regulators when integrin signaling is collaborative with TGF-beta1 pathways.

Citing Articles

The Small GTPase RAC1B: A Potent Negative Regulator of-and Useful Tool to Study-TGFβ Signaling.

Ungefroren H, Wellner U, Keck T, Lehnert H, Marquardt J Cancers (Basel). 2020; 12(11).

PMID: 33266416 PMC: 7700615. DOI: 10.3390/cancers12113475.


Expression of CDKN1A/p21 and TGFBR2 in breast cancer and their prognostic significance.

Wei C, Tan Q, Zhu X, Qin Q, Zhu F, Mo Q Int J Clin Exp Pathol. 2016; 8(11):14619-29.

PMID: 26823785 PMC: 4713571.


Dasatinib inhibits TGFβ-induced myofibroblast differentiation through Src-SRF Pathway.

Abdalla M, Thompson L, Gurley E, Burke S, Ujjin J, Newsome R Eur J Pharmacol. 2015; 769:134-42.

PMID: 26548624 PMC: 4679708. DOI: 10.1016/j.ejphar.2015.11.008.


AFAP1 Is a Novel Downstream Mediator of TGF-β1 for CCN2 Induction in Osteoblasts.

Cho Y, Silverstein R, Geisinger M, Martinkovich S, Corkill H, Cunnick J PLoS One. 2015; 10(9):e0136712.

PMID: 26340021 PMC: 4560384. DOI: 10.1371/journal.pone.0136712.


Hepatic stellate cells: central modulators of hepatic carcinogenesis.

Thompson A, Conroy K, Henderson N BMC Gastroenterol. 2015; 15:63.

PMID: 26013123 PMC: 4445994. DOI: 10.1186/s12876-015-0291-5.